ORIONISBIO Trademark
Trademark Overview
On Tuesday, January 2, 2024, a trademark application was filed for ORIONISBIO with the United States Patent and Trademark Office. The USPTO has given the ORIONISBIO trademark a serial number of 98338329. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, April 11, 2025. This trademark is owned by Orionis Biosciences Inc.. The ORIONISBIO trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical products, serums and preparations for the treatment of cancer, auto immune disorders, metabolic disorders, neurological disorders, neuromuscular disorder; Pharmaceutical preparations, namely, cytokine inhibitory drugs; Therapeutic pharmaceutical and diagnostic preparations, namely, antibodies, cytokines, antigens, enzymes, immunoconjugates for treatment of cancer, immunological conditions, metabolic disorders; Biochemical and small molecule preparations for medical purposes for use in the treatment of cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases
Diagnostic, biological and chemical reagents for scientific and research use; Pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; Active chemical or biological ingredients for use in the manufacture of pharmaceuticals for treating cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases; Cytokines, namely, reagents for scientific and research use
Development of new technology for others in the field of biotechnology; Scientific research and laboratory research services in the medical, bacteriological and biotechnical fields; Biotechnical research; Technical consultation and research in the field of biotechnological research; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Research and development of pharmaceuticals for others; Scientific and medical research in the fields of oncology, immunology and immune-oncology, inflammation, immune-mediated diseases, protein homeostasis, epigenetics and protein metabolism
General Information
| Serial Number | 98338329 |
| Word Mark | ORIONISBIO |
| Filing Date | Tuesday, January 2, 2024 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Friday, April 11, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 3, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical products, serums and preparations for the treatment of cancer, auto immune disorders, metabolic disorders, neurological disorders, neuromuscular disorder; Pharmaceutical preparations, namely, cytokine inhibitory drugs; Therapeutic pharmaceutical and diagnostic preparations, namely, antibodies, cytokines, antigens, enzymes, immunoconjugates for treatment of cancer, immunological conditions, metabolic disorders; Biochemical and small molecule preparations for medical purposes for use in the treatment of cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases |
| Goods and Services | Diagnostic, biological and chemical reagents for scientific and research use; Pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; Active chemical or biological ingredients for use in the manufacture of pharmaceuticals for treating cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases; Cytokines, namely, reagents for scientific and research use |
| Goods and Services | Development of new technology for others in the field of biotechnology; Scientific research and laboratory research services in the medical, bacteriological and biotechnical fields; Biotechnical research; Technical consultation and research in the field of biotechnological research; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Research and development of pharmaceuticals for others; Scientific and medical research in the fields of oncology, immunology and immune-oncology, inflammation, immune-mediated diseases, protein homeostasis, epigenetics and protein metabolism |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 2, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 2, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 2, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Orionis Biosciences Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Waltham, MA 02451 |
| Party Name | Orionis Biosciences Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Waltham, MA 02451 |
Trademark Events
| Event Date | Event Description |
| Tuesday, January 2, 2024 | NEW APPLICATION ENTERED |
| Tuesday, April 16, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, July 30, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, July 30, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, July 30, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, July 30, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, July 30, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, July 30, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 14, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 3, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 3, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 29, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, April 10, 2025 | SOU TEAS EXTENSION RECEIVED |
| Friday, April 11, 2025 | SOU EXTENSION 1 FILED |
| Friday, April 11, 2025 | SOU EXTENSION 1 GRANTED |
| Friday, April 11, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
